ITI Pharma & Healthcare Fund
The fund maintains a heavily concentrated pharma-dominated portfolio with nearly 69% in pharmaceuticals and biotech, betting on sector strength through quality domestic players like Sun Pharma and Divi's. The top-10 concentration at 57% signals conviction in large-cap quality names, though this limits diversification benefits. Recent exits of smaller pharma players and increased cash positioning suggest the manager is becoming more selective, favoring established leaders while reducing exposure to niche players that may face pricing or competitive pressures.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Direct Growth | ₹18.3158 | — | — | — | — |
| Regular Growth | ₹16.7296 | +8.60% | +4.64% | +21.52% | — |
| Direct IDCW | ₹18.3137 | — | — | — | — |
| Regular IDCW | ₹16.7296 | — | — | — | — |
Portfolio Metrics(latest month)
vs Category Peers
Highly DifferentiatedActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight | |
|---|---|---|
| No new entries this month | ||
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited INE044A01036 | 12.40% |
| 2 | Divi's Laboratories Limited INE361B01024 | 8.83% |
| 3 | Apollo Hospitals Enterprise Limited INE437A01024 | 6.25% |
| 4 | Max Healthcare Institute Limited INE027H01010 | 5.22% |
| 5 | Torrent Pharmaceuticals Limited INE685A01028 | 4.82% |
| 6 | Lupin Limited INE326A01037 | 4.44% |
| 7 | Aurobindo Pharma Limited INE406A01037 | 4.36% |
| 8 | Laurus Labs Limited INE947Q01028 | 4.24% |
| 9 | Net Receivables / (Payables) nan | 3.12% |
| 10 | Fortis Healthcare Limited INE061F01013 | 3.11% |
| 11 | Cohance Lifesciences Limited INE03QK01018 | 3.08% |
| 12 | Neuland Laboratories Limited INE794A01010 | 3.05% |
| 13 | Alkem Laboratories Limited INE540L01014 | 2.93% |
| 14 | Glenmark Pharmaceuticals Limited INE935A01035 | 2.69% |
| 15 | Aster DM Healthcare Limited INE914M01019 | 2.24% |
| 16 | Mankind Pharma Limited INE634S01028 | 1.91% |
| 17 | Sai Life Sciences Limited INE570L01029 | 1.84% |
| 18 | Dr. Reddy's Laboratories Limited INE089A01031 | 1.82% |
| 19 | Abbott India Limited INE358A01014 | 1.79% |
| 20 | Park Medi World Limited INE119201023 | 1.67% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does ITI Pharma & Healthcare Fund hold?
ITI Pharma & Healthcare Fund holds 38 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 37.52% of NAV.
What is the largest holding in ITI Pharma & Healthcare Fund?
The largest position in ITI Pharma & Healthcare Fund is Sun Pharmaceutical Industries Limited, accounting for 12.40% of NAV in the Pharmaceuticals & Biotechnology sector.
Is ITI Pharma & Healthcare Fund a concentrated or diversified fund?
With a Gini coefficient of 0.436, ITI Pharma & Healthcare Fund is well-diversified. The HHI concentration index is 46,674 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 37.52% of the portfolio.
What is the market cap allocation of ITI Pharma & Healthcare Fund?
Based on SEBI's AMFI classification, ITI Pharma & Healthcare Fund's equity portfolio is split as: Large Cap: 42.24%, Mid Cap: 31.12%, Small Cap: 23.52%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does ITI Pharma & Healthcare Fund invest in most?
ITI Pharma & Healthcare Fund has the highest allocation to Pharmaceuticals & Biotechnology (68.96%), Healthcare Services (21.02%), nan (3.12%). The fund is invested across 7 sectors in total.
How actively managed is ITI Pharma & Healthcare Fund compared to other Sectoral / Thematic funds?
ITI Pharma & Healthcare Fund has an Active Share of 88.62%, classifying it as "Highly Differentiated" among 237 Sectoral / Thematic peers. This means the fund takes significantly different stock positions compared to its category peers.
What changed in ITI Pharma & Healthcare Fund's portfolio in the latest month?
Between 2026-03-31 and 2026-04-30, ITI Pharma & Healthcare Fund exited 4 stocks (including Sumitomo Chemical India Limited). Total holding count decreased from 43 to 39 stocks.